New role of Interleukin-10 in enhancing the antitumor efficacy of oncolytic vaccinia virus for treatment of pancreatic cancer

Por Chard, Louisa S, Lemoine, Nicholas R, Wang, Yaohe
Publicado no Oncoimmunology (2015)

Unique Characteristics of a Picornavirus Internal Ribosome Entry Site from the Porcine Teschovirus-1 Talfan

Por Kaku, Yoshihiro, Chard, Louisa S., Inoue, Toru, Belsham, Graham J.
Publicado em 2002

Functional Analyses of RNA Structures Shared between the Internal Ribosome Entry Sites of Hepatitis C Virus and the Picornavirus Porcine Teschovirus 1 Talfan

Por Chard, Louisa S., Kaku, Yoshihiro, Jones, Barbara, Nayak, Arabinda, Belsham, Graham J.
Publicado em 2006

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Por Yuan, Ming, Wang, Pengju, Chard, Louisa S., Lemoine, Nicholas R., Wang, Yaohe
Publicado no J Vis Exp (2016)

Functional and Structural Similarities between the Internal Ribosome Entry Sites of Hepatitis C Virus and Porcine Teschovirus, a Picornavirus

Por Pisarev, Andrey V., Chard, Louisa S., Kaku, Yoshihiro, Johns, Helen L., Shatsky, Ivan N., Belsham, Graham J.
Publicado em 2004

Vascular Endothelial Growth Factor A Promotes Vaccinia Virus Entry into Host Cells via Activation of the Akt Pathway

Por Hiley, Crispin T., Chard, Louisa S., Gangeswaran, Rathi, Tysome, James R., Briat, Arnaud, Lemoine, Nicholas R., Wang, Yaohe
Publicado em 2013

Efficiently Editing the Vaccinia Virus Genome by Using the CRISPR-Cas9 System

Por Yuan, Ming, Zhang, Wensheng, Wang, Jun, Al Yaghchi, Chadwan, Ahmed, Jahangir, Chard, Louisa, Lemoine, Nick R., Wang, Yaohe
Publicado no J Virol (2015)

A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9

Por Yuan, Ming, Gao, Xuefei, Chard, Louisa S, Ali, Zarah, Ahmed, Jahangir, Li, Yunqing, Liu, Pentao, Lemoine, Nick R, Wang, Yaohe
Publicado no Mol Ther Methods Clin Dev (2015)

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Por Wang, Pengju, Li, Xiaozhu, Wang, Jiwei, Gao, Dongling, Li, Yuenan, Li, Haoze, Chu, Yongchao, Zhang, Zhongxian, Liu, Hongtao, Jiang, Guozhong, Cheng, Zhenguo, Wang, Shengdian, Dong, Jianzeng, Feng, Baisui, Chard, Louisa S., Lemoine, Nicholas R., Wang, Yaohe
Publicado no Nat Commun (2017)

Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Por Wang, Pengju, Li, Xiaozhu, Wang, Jiwei, Gao, Dongling, Li, Yuenan, Li, Haoze, Chu, Yongchao, Zhang, Zhongxian, Liu, Hongtao, Jiang, Guozhong, Cheng, Zhenguo, Wang, Shengdian, Dong, Jianzeng, Feng, Baisui, Chard, Louisa S, Lemoine, Nicholas R, Wang, Yaohe
Publicado no Nat Commun (2018)